Recruiting Myelodysplastic Syndromes Studies in Duarte
The Efficacy and Safety of Elritercept in Adult Participants With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) With Anemia (RENEW)
This study (KER-050-D301) is evaluating the efficacy and safety of elritercept (KER-050) versus placebo in adult participants with transfusion-dependent anemia with very low, low, or intermediate risk...
A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
The purpose of this study is to evaluate the effects of KER-050 on anemia in patients with very low, low or intermediate risk MDS....
About Myelodysplastic Syndromes Clinical Trials in Duarte
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
There are currently 2 myelodysplastic syndromes clinical trials recruiting participants in Duarte, CALIFORNIA. These studies are seeking a combined 365 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelodysplastic Syndromes Clinical Trials in Duarte — FAQ
Are there myelodysplastic syndromes clinical trials in Duarte?
Yes, there are 2 myelodysplastic syndromes clinical trials currently recruiting in Duarte, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Duarte?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.
Are clinical trials in Duarte free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.
What myelodysplastic syndromes treatments are being tested?
The 2 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for myelodysplastic syndromes.
Data updated March 2, 2026 from ClinicalTrials.gov